Compulsive Gambling

Adapted Couple Therapy (ACT) for pathological gamblers: a promising avenue
The study of the effectiveness of treatment for pathological gambling constitutes a field that is still largely unexplored.
1111, rue St-Charles Ouest, Tour Ouest, Bureau 500, Longueuil
Quebec City, Canada J4K 5G4
Canada
Gambling initiation in preadolescents
Gambling has increased in the past decade, with growing opportunities for initiation by adolescents.

Philadelphia, PA 19104
USA
Dopamine agonist increases risk taking but blunts reward-related brain activity
The use of D2/D3 dopaminergic agonists in Parkinson's disease (PD) may lead to pathological gambling.

Magdeburg, Germany
Germany
Subtyping pathological gamblers on the basis of affective motivations for gambling: relations to gam
Pathological gamblers who drink when gambling (n=158; 77% men; mean age=36.0 years) completed the Inventory of Gambling Situations (IGS) and gambling and drinking criterion measures.

Halifax, Nova Scotia
Canada
Gambling and health risk-taking behavior in a military sample
This study examined the gambling of a cohort of U.S. Air Force recruits (N = 31,104) and the relationship between their gambling and health-risk behaviors.
4201 South Washington
Marion, IN 46953
USA
Personality traits and disorders in pathological gamblers versus normal controls
AIMS: To establish the personality traits and disorders of pathological gamblers in treatment by means of a descriptive cross-sectional study of two prospective matched-pair cohorts: 50 pathological gamblers versus a control group of 50 normal volunteers (non-patient and non-pathological gamblers).

Valencia, Spain
Spain
Significant Others and Gambling Treatment Outcomes
Aims This study investigates the effect of significant others on treatment outcomes among treated pathological gamblers.

Portland, OR
USA
A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological
Emerging evidence suggests that dopaminergic and serotonergic functioning are altered in pathological gamblers; yet, there are no FDA-approved medications for pathological gambling and there have only been a limited number of clinical trials that have been conducted.
760 Westwood Boulevard, Room C8-887
Los Angeles, CA 90024
USA
Olanzapine in the Treatment of Pathological Gambling: A Negative Randomized Placebo-Controlled Trial
OBJECTIVE: Pathological gambling is associated with bipolar disorder and dopamine dysfunction.

Cincinnati, OH
USA
[Gambling and suicidal behaviour]
BACKGROUND: The negative consequences of pathological gambling are related to social, economical and relational problems.
Øvre Slottsgate 2b, 0105
Oslo, Norway
Norway